SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTP ICAP Regulatory News (TCAP)

Share Price Information for TP ICAP (TCAP)

Share Price is delayed by 15 minutes
Get Live Data
344.20    8.00 (2.38%)
Bid:
344.00
Ask:
344.40
Spread: 0.40 (0.116%)
Market Cap: £2.51b
TCAP Live PriceLast checked at - London Stock Exchange

Intraday TP ICAP Share Chart

Trading Statement

5 Nov 2024 07:00

RNS Number : 8888K
TP ICAP Group plc
05 November 2024
 

TP ICAP GROUP PLC (the "Group")

 

5 November 2024

 

Trading Update for the nine months ended 30 September 2024

 

 

Third quarter performance in constant currency, unless in brackets, which denotes reported currency

 

Record Group revenue in the third quarter of £557m, up 10% (+9% in reported currency).

 

Global Broking revenue increased 9% (+8%), maintaining the good second quarter momentum. Rates, the largest and most profitable asset class, grew 14% (+15%), benefitting from interest rate volatility.

 

Liquidnet delivered a very strong third quarter, with revenue up 28% (+26%). Liquidnet Equities recorded a 24% (+21%) increase, against a backdrop of continued institutional block market activity. Multi-asset agency brokerage revenue was up 33% (+33%), driven by strong growth in Relative Value strategies.

 

Energy & Commodities (E&C) revenue increased 3% (+2%), following a record third quarter last year.

 

Parameta Solutions, our market-leading over-the-counter (OTC) data business, grew 9% (+6%).

 

Nine-month performance in constant currency, unless in brackets, which denotes reported currency

 

Group revenue of £1,701m, up 5% (+3% in reported currency). All four divisions traded well, underlining the broad, diversified nature of the Group.

 

Global Broking revenue increased 3% (+1%), benefiting from favourable market conditions, with ongoing volatility across key asset classes, particularly Rates.

 

Liquidnet posted a 14% (+11%) increase in revenue, as growth accelerated following a strong first half, when revenue increased 8%. Liquidnet Equities grew 18% (+14%), whilst multi-asset agency brokerage reported 9% (+8%) growth.

 

E&C revenue grew 6% (+4%).

 

Parameta Solutions revenue was up 10% (+7%).

 

The Board is comfortable with FY 2024 market expectations for adjusted EBIT, subject to the impact of FX movements, especially the US Dollar (USD) against sterling. Approximately 60% of Group revenues and 40% of Group costs are USD-denominated.

 

Business Update

 

The Group is focused on delivering its three strategic priorities - Transformation, Diversification and Dynamic Capital Management - and will update on progress when it publishes, on 11 March 2025, its 2024 Preliminary Results. As previously announced at the Group's Interim Results in August, we are progressing strategic options in relation to Parameta Solutions. They include a potential offering, which might entail a listing in the United States, with the Group maintaining a majority stake. There is no certainty about either a public offering, or its location.

 

Forward looking statements

This document contains forward looking statements with respect to the financial condition, results and business of the Company. By their nature, forward looking statements involve risk and uncertainty and there may be subsequent variations to estimates. The Company's actual future results may differ materially from the results expressed or implied in these forward-looking statements.

 

Enquiries

Group Company Secretary Vicky Hart

Email: companysecretarial@tpicap.com

 

Analysts and investors Dominic Lagan Direct: +44 (0) 20 3933 0447

Email: dominic.lagan@tpicap.com  

Media Richard Newman Direct: +44 (0) 7469 039 307

Email: richard.newman@tpicap.com

  

About TP ICAP

·

TP ICAP connects buyers and sellers in global financial, energy and commodities markets.

·

It is the world's leading wholesale market intermediary, with a portfolio of businesses that provide broking services, data & analytics and market intelligence, trusted by clients around the world.

·

We operate from more than 60 offices across 28 countries, supporting brokers with award-winning and market-leading technology.

 

 

Further information on the company and its activities is available on the Company's website:

www.tpicap.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFFFSFLILSIIS
Date   Source Headline
27th Mar 20257:00 amRNSTransaction in Own Shares
26th Mar 20257:00 amRNSTransaction in Own Shares
25th Mar 20257:00 amRNSTransaction in Own Shares
24th Mar 20254:45 pmRNSHolding(s) in Company
24th Mar 20257:00 amRNSTransaction in Own Shares
21st Mar 20257:00 amRNSTransaction in Own Shares
20th Mar 20257:00 amRNSTransaction in Own Shares
19th Mar 20257:00 amRNSTransaction in Own Shares
18th Mar 20257:00 amRNSTransaction in Own Shares
17th Mar 20257:00 amRNSTransaction in Own Shares
14th Mar 20257:00 amRNSTransaction in Own Shares
13th Mar 20257:00 amRNSTransaction in Own Shares
12th Mar 20254:30 pmRNSHolding(s) in Company
12th Mar 20257:00 amRNSTransaction in Own Shares
11th Mar 20257:05 amRNSLaunch of fourth share buyback programme of £30m
11th Mar 20257:00 amRNSFinal Results
6th Mar 20254:35 pmRNSHolding(s) in Company
13th Feb 20258:00 amRNSHolding(s) in Company
10th Feb 20254:30 pmRNSHolding(s) in Company
23rd Jan 20255:30 pmRNSDirectorate Change
17th Jan 20252:45 pmRNSHolding(s) in Company
17th Jan 20257:00 amRNSTransaction in Own Shares
16th Jan 20257:00 amRNSTransaction in Own Shares
15th Jan 20257:00 amRNSTransaction in Own Shares
14th Jan 20257:00 amRNSTransaction in Own Shares
13th Jan 20257:00 amRNSTransaction in Own Shares
10th Jan 20257:00 amRNSTransaction in Own Shares
9th Jan 20257:00 amRNSTransaction in Own Shares
8th Jan 20257:00 amRNSTransaction in Own Shares
7th Jan 20257:00 amRNSTransaction in Own Shares
6th Jan 20257:00 amRNSTransaction in Own Shares
3rd Jan 20257:00 amRNSTransaction in Own Shares
2nd Jan 20257:00 amRNSTransaction in Own Shares
31st Dec 20247:00 amRNSTransaction in Own Shares
30th Dec 20247:00 amRNSTransaction in Own Shares
27th Dec 20247:00 amRNSTransaction in Own Shares
24th Dec 20247:00 amRNSTransaction in Own Shares
23rd Dec 20247:00 amRNSTransaction in Own Shares
20th Dec 202410:21 amRNSHolding(s) in Company
20th Dec 20247:00 amRNSTransaction in Own Shares
14th Nov 20247:00 amRNSTransaction in Own Shares
13th Nov 20244:15 pmRNSHolding(s) in Company
13th Nov 20243:00 pmRNSDirector/PDMR Shareholding
13th Nov 20247:00 amRNSTransaction in Own Shares
12th Nov 20247:00 amRNSTransaction in Own Shares
11th Nov 20247:00 amRNSTransaction in Own Shares
6th Nov 20247:00 amRNSTransaction in Own Shares
5th Nov 20247:05 amRNSTransaction in Own Shares
5th Nov 20247:00 amRNSTrading Statement
4th Nov 20247:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.